NCT04812951View on ClinicalTrials.gov

Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

February 17, 2021

Primary Completion Date

June 18, 2021

Study Completion Date

February 23, 2022

Conditions
Ocular Surface DiseaseOcular Inflammation
Interventions
DRUG

CycloSPORINE Ophthalmic 0.1% Ophthalmic Emulsion

one cyclosporine 0.1% eye drop twice a day for 30 preoperative days

DEVICE

cationorm eye drops

one cationorm eye drop twice a day for 30 preoperative days

Trial Locations (1)

00128

University Campus Bio Medico, Rome

All Listed Sponsors
lead

Campus Bio-Medico University

OTHER

NCT04812951 - Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract Surgery | Biotech Hunter | Biotech Hunter